Sichuan Kelun Pharmaceutical Co., Ltd. Class A
002422
Classifica tra le azioni
#2010
Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and... Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China and internationally. The company operates through Chuanning, Botai, and Other Business segments. The company offers infusion products; oral medication and other dosage form; medical devices, such as infusion sets, sterile dispensing and injection syringes, vein detained needles, nebulizer sets, and vacuum blood collection tubes; over-the-counter products; and APIs to treat cardiovascular, IPF, ED, anti-tumor, anti-emetic, antibiotic, VB12, anti-rheumatoid arthritis, multiple sclerosis, anti-schizophrenia, CKD and anti-anemia, polypeptide, and other indications. It also provides ambroxol hydrochloride, potassium chloride, sodium chloride, magnesium sulfate, glucose, sterile water, sodium bicarbonate, lidocaine hydrochloride, vitamin B6, ribavirin, ceftazidime, 5% glucose, and ceftriaxone sodium injections. In addition, the company engages in investment; import and export; enterprise management; logistics and transportation; business services; agricultural non-staple food processing; production and sale of pharmaceutical intermediates; research and development of bio-based materials technology; Internet and related services; crop planting; professional technical; biotechnology extension; socio-economic consultation; technology promotion; medical research and testing exhibition; general cargo road transport; ecological protection and environmental management; and wholesale and retail. It exports its products to Japan. The company was formerly known as Sichuan Kelun Pharmaceutical Factory Co., Ltd and changed its name to Sichuan Kelun Pharmaceutical Co., Ltd. in August 2003. The company was founded in 1996 and is based in Chengdu, the People's Republic of China. Sichuan Kelun Pharmaceutical Co., Ltd. operates as a subsidiary of Sichuan Kelun Industry Group CO., LTD.
Prezzo delle azioni
$6.40
Capitalizzazione di mercato
$10.19B
Variazione (1 giorno)
-0.77%
Variazione (1 anno)
27.14%
Paese
CN
Scambia Sichuan Kelun Pharmaceutical Co., Ltd. Class A (002422)
Categoria
Healthcare
Numero di azioni in circolazione per Sichuan Kelun Pharmaceutical Co., Ltd. Class A (002422)
Numero di azioni in circolazione al June 2026: 1.59B
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Sichuan Kelun Pharmaceutical Co., Ltd. Class A, il numero attuale di azioni in circolazione è 1.59B. Alla fine del December 2024, la società aveva 1.58B azioni in circolazione. Il numero di azioni in circolazione è solitamente influenzato da split azionari e riacquisti.
Storico delle azioni in circolazione di Sichuan Kelun Pharmaceutical Co., Ltd. Class A (002422) dal 2007 al 2026
Azioni in circolazione alla fine di ogni anno
| Anno | Azioni in circolazione | Cambia |
|---|---|---|
| 2026 (TTM) | 1.59B | -0.01% |
| 2025 | 1.59B | 0.77% |
| 2024 | 1.58B | 8.61% |
| 2023 | 1.45B | 3.77% |
| 2022 | 1.40B | -0.92% |
| 2021 | 1.41B | -1.15% |
| 2020 | 1.43B | 0.63% |
| 2019 | 1.42B | -0.42% |
| 2018 | 1.43B | -0.30% |
| 2017 | 1.43B | 0.37% |
| 2016 | 1.43B | -0.56% |
| 2015 | 1.43B | 0.18% |
| 2014 | 1.43B | -0.56% |
| 2013 | 1.44B | 0.15% |
| 2012 | 1.44B | -0.33% |
| 2011 | 1.44B | 11.95% |
| 2010 | 1.29B | 19.42% |
| 2009 | 1.08B | 1.52% |
| 2008 | 1.06B | 4.80% |
| 2007 | 1.01B | 0.00% |
Azioni in circolazione per aziende simili o concorrenti
| Azienda | Azioni in circolazione | Differenza | Il paese |
|---|---|---|---|
| 253.90M | -84.04% |
US
|
|
| 396.00M | -75.10% |
US
|
|
| 478.91M | -69.89% |
AU
|
|
| 0.00 | -100.00% |
BE
|
|
| 62.19M | -96.09% |
NL
|
